Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

182 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Methods proposed for monitoring the implementation of evidence-based research: a cross-sectional study.
Puljak L, Bala MM, Zając J, Meštrović T, Buttigieg S, Yanakoulia M, Briel M, Lunny C, Lesniak W, Poklepović Peričić T, Alonso-Coello P, Clarke M, Djulbegovic B, Gartlehner G, Giannakou K, Glenny AM, Glenton C, Guyatt G, Hemkens LG, Ioannidis JPA, Jaeschke R, Juhl Jørgensen K, Martins-Pfeifer CC, Marušić A, Mbuagbaw L, Meneses Echavez JF, Moher D, Nussbaumer-Streit B, Page MJ, Pérez-Gaxiola G, Robinson KA, Salanti G, Saldanha IJ, Savović J, Thomas J, Tricco AC, Tugwell P, van Hoof J, Pieper D. Puljak L, et al. Among authors: van hoof j. J Clin Epidemiol. 2024 Apr;168:111247. doi: 10.1016/j.jclinepi.2024.111247. Epub 2024 Jan 5. J Clin Epidemiol. 2024. PMID: 38185190
WPA Volunteering Programme: lessons learnt so far.
Chumakov E, Thomson S, Allan J, Hermans MHM, van Hoof J, Hughes P, Ng B, Savage M, Ng RMK. Chumakov E, et al. Among authors: van hoof j. World Psychiatry. 2024 Feb;23(1):171-172. doi: 10.1002/wps.21181. World Psychiatry. 2024. PMID: 38214617 Free PMC article. No abstract available.
Non-human primate to human immunobridging demonstrates a protective effect of Ad26.ZEBOV, MVA-BN-Filo vaccine against Ebola.
Bockstal V, Leyssen M, Heerwegh D, Spiessens B, Robinson C, Stoop JN, Roozendaal R, Van Effelterre T, Gaddah A, Van Roey GA, Solforosi L, Zahn R, Callendret B, Hendriks J, Luhn K, Douoguih M, Schuitemaker H, Van Hoof J. Bockstal V, et al. Among authors: van hoof j. NPJ Vaccines. 2022 Nov 30;7(1):156. doi: 10.1038/s41541-022-00564-z. NPJ Vaccines. 2022. PMID: 36450746 Free PMC article.
Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2): results of a randomised, double-blind, placebo-controlled, phase 3 trial.
Hardt K, Vandebosch A, Sadoff J, Le Gars M, Truyers C, Lowson D, Van Dromme I, Vingerhoets J, Kamphuis T, Scheper G, Ruiz-Guiñazú J, Faust SN, Spinner CD, Schuitemaker H, Van Hoof J, Douoguih M, Struyf F; ENSEMBLE2 study group. Hardt K, et al. Among authors: van hoof j. Lancet Infect Dis. 2022 Dec;22(12):1703-1715. doi: 10.1016/S1473-3099(22)00506-0. Epub 2022 Sep 13. Lancet Infect Dis. 2022. PMID: 36113538 Free PMC article. Clinical Trial.
Durable antibody responses elicited by 1 dose of Ad26.COV2.S and substantial increase after boosting: 2 randomized clinical trials.
Sadoff J, Le Gars M, Brandenburg B, Cárdenas V, Shukarev G, Vaissiere N, Heerwegh D, Truyers C, de Groot AM, Jongeneelen M, Kaszas K, Tolboom J, Scheper G, Hendriks J, Ruiz-Guiñazú J, Struyf F, Van Hoof J, Douoguih M, Schuitemaker H. Sadoff J, et al. Among authors: van hoof j. Vaccine. 2022 Jul 30;40(32):4403-4411. doi: 10.1016/j.vaccine.2022.05.047. Epub 2022 Jun 3. Vaccine. 2022. PMID: 35667914 Free PMC article.
182 results